D. E. Shaw & Co., Inc. Eiger Bio Pharmaceuticals, Inc. Transaction History

D. E. Shaw & Co., Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.02 - $7.48 $56,822 - $416,695	-55,708 Reduced 54.51%	46,496 $54,000
Q3 2022 Nov 14, 2022	SELL	$6.04 - $9.66 $933,838 - $1.49 Million	-154,609 Reduced 60.2%	102,204 $770,000
Q2 2022 Aug 15, 2022	SELL	$4.99 - $8.96 $395,377 - $709,936	-79,234 Reduced 23.58%	256,813 $1.62 Million
Q1 2022 May 16, 2022	BUY	$3.84 - $9.74 $1.18 Million - $2.99 Million	307,080 Added 1060.1%	336,047 $2.79 Million
Q4 2021 Feb 14, 2022	BUY	$5.12 - $8.19 $148,311 - $237,239	28,967 New	28,967 $150,000
Q1 2021 May 17, 2021	SELL	$8.44 - $12.66 $196,609 - $294,914	-23,295 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$7.98 - $12.29 $583,401 - $898,497	-73,108 Reduced 75.84%	23,295 $286,000
Q3 2020 Nov 16, 2020	SELL	$7.96 - $12.42 $966,423 - $1.51 Million	-121,410 Reduced 55.74%	96,403 $785,000
Q2 2020 Aug 14, 2020	BUY	$5.4 - $13.37 $768,879 - $1.9 Million	142,385 Added 188.77%	217,813 $2.09 Million
Q1 2020 May 15, 2020	BUY	$4.91 - $14.7 $97,664 - $292,397	19,891 Added 35.82%	75,428 $513,000
Q4 2019 Feb 14, 2020	BUY	$9.77 - $15.66 $401,400 - $643,391	41,085 Added 284.29%	55,537 $827,000
Q3 2019 Nov 14, 2019	BUY	$9.59 - $12.0 $138,594 - $173,424	14,452 New	14,452 $148,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $76.1M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.